Augmedix, Inc. (AUGX)
2.350
0.00 (0.00%)
Inactive · Last trade price on Oct 1, 2024
Augmedix Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue Revenue Growth | 51.58 | 44.86 | 30.93 | 22.17 | 16.48 | 14.11 |
Revenue Growth | 39.33% | 45.01% | 39.56% | 34.47% | 16.84% | 30.44% |
Gross Profit Gross Profit Growth | 24.87 | 21.53 | 13.95 | 10.01 | 6.79 | 4.68 |
Operating Income Operating Income Growth | -23.88 | -18.78 | -22.37 | -17.55 | -13.69 | -16.74 |
Net Income Net Income Growth | -23.85 | -19.17 | -24.45 | -17.46 | -15.6 | -18.5 |
Earnings Per Share EPS Growth | -0.47 | -0.44 | -0.65 | -0.60 | -2.22 | -22.24 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Investments Cash & Investments Growth | 28.22 | 46.22 | 21.25 | 41.26 | 20.76 | 9.6 |
Total Debt Total Debt Growth | 25.28 | 25.85 | 16.97 | 14.84 | 14.95 | 12.62 |
Net Cash (Debt) Net Cash Growth | 2.95 | 20.37 | 4.28 | 26.42 | 5.81 | -3.01 |
Net Cash Growth | 314.20% | 376.29% | -83.81% | 354.62% | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.06 | 0.46 | 0.11 | 0.91 | 0.83 | -3.62 |
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Operating Cash Flow Operating Cash Flow Growth | -15.31 | -15.44 | -16.77 | -18.59 | -14.4 | -14.65 |
Capital Expenditures CapEx Growth | -2.56 | -3.11 | -1.41 | -0.61 | -0.65 | -0.82 |
Free Cash Flow Free Cash Flow Growth | -17.87 | -18.55 | -18.18 | -19.2 | -15.05 | -15.47 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Gross Margin | 48.22% | 47.99% | 45.11% | 45.15% | 41.22% | 33.17% |
Operating Margin | -46.29% | -41.87% | -72.32% | -79.18% | -83.07% | -118.68% |
Pretax Margin | -46.10% | -42.42% | -78.68% | -78.58% | -94.67% | -131.12% |
Profit Margin | -46.23% | -42.74% | -79.04% | -78.79% | -94.67% | -131.12% |
FCF Margin | -34.65% | -41.35% | -58.78% | -86.64% | -91.28% | -109.65% |
| Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
PS Ratio | 2.29 | 6.33 | 1.89 | 5.28 | - | - |